TY - JOUR
T1 - A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents
AU - Teruya, Kenta
AU - Oguma, Ayumi
AU - Nishizawa, Keiko
AU - Kawata, Maki
AU - Sakasegawa, Yuji
AU - Kamitakahara, Hiroshi
AU - Doh-ura, Katsumi
N1 - Publisher Copyright:
© 2016 Teruya et al.
PY - 2016/12/14
Y1 - 2016/12/14
N2 - Prion diseases are fatal, progressive, neurodegenerative diseases caused by prion accumulation in the brain and lymphoreticular system. Here we report that a single subcutaneous injection of cellulose ethers (CEs), which are commonly used as inactive ingredients in foods and pharmaceuticals, markedly prolonged the lives of mice and hamsters intracerebrally or intraperitoneally infected with the 263K hamster prion. CEs provided sustained protection even when a single injection was given as long as one year before infection. These effects were linked with persistent residues of CEs in various tissues. More effective CEs had less macrophage uptake ratios and hydrophobic modification of CEs abolished the effectiveness. CEs were significantly effective in other prion disease animal models; however, the effects were less remarkable than those observed in the 263K prion-infected animals. The genetic background of the animal model was suggested to influence the effects of CEs. CEs did not modify prion protein expression but inhibited abnormal prion protein formation in vitro and in prion-infected cells. Although the mechanism of CEs in vivo remains to be solved, these findings suggest that they aid in elucidating disease susceptibility and preventing prion diseases.
AB - Prion diseases are fatal, progressive, neurodegenerative diseases caused by prion accumulation in the brain and lymphoreticular system. Here we report that a single subcutaneous injection of cellulose ethers (CEs), which are commonly used as inactive ingredients in foods and pharmaceuticals, markedly prolonged the lives of mice and hamsters intracerebrally or intraperitoneally infected with the 263K hamster prion. CEs provided sustained protection even when a single injection was given as long as one year before infection. These effects were linked with persistent residues of CEs in various tissues. More effective CEs had less macrophage uptake ratios and hydrophobic modification of CEs abolished the effectiveness. CEs were significantly effective in other prion disease animal models; however, the effects were less remarkable than those observed in the 263K prion-infected animals. The genetic background of the animal model was suggested to influence the effects of CEs. CEs did not modify prion protein expression but inhibited abnormal prion protein formation in vitro and in prion-infected cells. Although the mechanism of CEs in vivo remains to be solved, these findings suggest that they aid in elucidating disease susceptibility and preventing prion diseases.
UR - http://www.scopus.com/inward/record.url?scp=85007545269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007545269&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1006045
DO - 10.1371/journal.ppat.1006045
M3 - Article
C2 - 27973536
AN - SCOPUS:85007545269
SN - 1553-7366
VL - 12
JO - PLoS Pathogens
JF - PLoS Pathogens
IS - 12
M1 - e1006045
ER -